Microdosing GLP-1: What It Means and What to Watch Out For

Microdosing is an informal term for taking a lower dose of a GLP-1 (such as semaglutide or tirzepatide) than the standard labeled escalation — for example staying at a starting or sub-therapeutic dose rather than titrating all the way up. It is not an official medical term, not an FDA-approved protocol, and there is no standardized “microdose.” Any dosing should be set by your prescriber.

Common reasons people cite are: fewer or milder gastrointestinal side effects, “maintenance” after reaching a goal weight, stretching limited or expensive supply, or simply feeling that a lower dose is enough for them. These are personal/anecdotal motivations — they are not the same as proven, guideline-backed strategies.

Evidence is limited. The pivotal trials that established GLP-1 weight-loss results used the full labeled doses, so lower-dose outcomes are not well characterized in high-quality studies. Some people do see appetite reduction at lower doses; others under-treat and stall. Because it isn’t standardized or well-studied, results are unpredictable — discuss expectations with your clinician.

A lower dose isn’t automatically safer, and microdosing carries its own issues: it is frequently done with compounded products (which are not FDA-reviewed for safety, quality, or effectiveness), it can involve self-adjusting doses without supervision, and under-dosing may waste months of treatment. The safest path is a supervised dose plan with a licensed prescriber, not a self-directed protocol.

There is no standard microdose, and we don’t publish dose amounts — dosing is a medical decision that depends on the drug, your response, and your health, and getting it wrong can mean side effects or no benefit. If you and your prescriber decide a lower dose makes sense for you, they will set it and monitor you. Never self-dose from online instructions.

No. GLP-1 medications are FDA-approved at specific labeled doses and titration schedules; “microdosing” is an off-label practice that falls outside those instructions. Off-label use is legal when a licensed clinician decides it’s appropriate for you, but it is not an FDA-endorsed strategy.